Detalhe da pesquisa
1.
The PARTNER trial of neoadjuvant olaparib with chemotherapy in triple-negative breast cancer.
Nature
; 629(8014): 1142-1148, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38588696
2.
A UK prospective multicentre decision impact, decision conflict and economic evaluation of the 21-gene assay in women with node+ve, hormone receptor+ve, HER2-ve breast cancer.
Br J Cancer
; 130(7): 1149-1156, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38308000
3.
Afatinib alone and in combination with vinorelbine or paclitaxel, in patients with HER2-positive breast cancer who failed or progressed on prior trastuzumab and/or lapatinib (LUX-Breast 2): an open-label, multicenter, phase II trial.
Breast Cancer Res Treat
; 192(3): 593-602, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35138529
4.
Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis (New EPOC): long-term results of a multicentre, randomised, controlled, phase 3 trial.
Lancet Oncol
; 21(3): 398-411, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32014119
5.
Association of post-operative CEA with survival and oxaliplatin benefit in patients with stage II colon cancer: a post hoc analysis of the MOSAIC trial.
Br J Cancer
; 121(4): 312-317, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31296923
6.
3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): an international, randomised, phase 3, non-inferiority trial.
Lancet Oncol
; 19(4): 562-578, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29611518
7.
SCOT: a comparison of cost-effectiveness from a large randomised phase III trial of two durations of adjuvant Oxaliplatin combination chemotherapy for colorectal cancer.
Br J Cancer
; 119(11): 1332-1338, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30420616
8.
MABp1 as a novel antibody treatment for advanced colorectal cancer: a randomised, double-blind, placebo-controlled, phase 3 study.
Lancet Oncol
; 18(2): 192-201, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-28094194
9.
Vandetanib plus gemcitabine versus placebo plus gemcitabine in locally advanced or metastatic pancreatic carcinoma (ViP): a prospective, randomised, double-blind, multicentre phase 2 trial.
Lancet Oncol
; 18(4): 486-499, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28259610
10.
Addition of gemcitabine to paclitaxel, epirubicin, and cyclophosphamide adjuvant chemotherapy for women with early-stage breast cancer (tAnGo): final 10-year follow-up of an open-label, randomised, phase 3 trial.
Lancet Oncol
; 18(6): 755-769, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28479233
11.
Central pathology review with two-stage quality assurance for pathological response after neoadjuvant chemotherapy in the ARTemis Trial.
Mod Pathol
; 30(8): 1069-1077, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28548129
12.
Increased DNA Methylation of ABCB1, CYP2D6, and OPRM1 Genes in Newborn Infants of Methadone-Maintained Opioid-Dependent Mothers.
J Pediatr
; 190: 180-184.e1, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28867064
13.
Computational pathology of pre-treatment biopsies identifies lymphocyte density as a predictor of response to neoadjuvant chemotherapy in breast cancer.
Breast Cancer Res
; 18(1): 21, 2016 Feb 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-26882907
14.
Patterns of progression, treatment of progressive disease and post-progression survival in the New EPOC study.
Br J Cancer
; 115(4): 420-4, 2016 Aug 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27434036
15.
Efficacy of neoadjuvant bevacizumab added to docetaxel followed by fluorouracil, epirubicin, and cyclophosphamide, for women with HER2-negative early breast cancer (ARTemis): an open-label, randomised, phase 3 trial.
Lancet Oncol
; 16(6): 656-66, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25975632
16.
A meta-analysis of prevalence rates and moderating factors for cancer-related post-traumatic stress disorder.
Psychooncology
; 24(4): 371-81, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25146298
17.
Effects of the addition of gemcitabine, and paclitaxel-first sequencing, in neoadjuvant sequential epirubicin, cyclophosphamide, and paclitaxel for women with high-risk early breast cancer (Neo-tAnGo): an open-label, 2×2 factorial randomised phase 3 trial.
Lancet Oncol
; 15(2): 201-12, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24360787
18.
Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis: the New EPOC randomised controlled trial.
Lancet Oncol
; 15(6): 601-11, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24717919
19.
Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trial.
Lancet Oncol
; 15(8): 829-40, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24954781
20.
Randomized Phase II trial of nintedanib, afatinib and sequential combination in castration-resistant prostate cancer.
Future Oncol
; 10(2): 219-31, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24490608